{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:50:51Z","timestamp":1765374651792,"version":"3.46.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    Carotid body tumor (CBT) is the most common head and neck paraganglioma with the very rare occurrence of distant metastases. The widespread distant metastases in head and neck paraganglioma have limited treatment options, with peptide receptor radionuclide therapy (PRRT) being an effective treatment in somatostatin receptor-expressing lesions. Here is a case of a 45-year-old woman with metastatic CBT who showed excellent response initially to\n                    <jats:sup>177<\/jats:sup>\n                    Lu-DOTATATE PRRT, but presented later in wheel-chair bound condition with metastatic lesions and spinal cord compression at multiple levels, which again showed exceptional response to rechallenge PRRT.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005930","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:00:40Z","timestamp":1746086440000},"page":"e52-e54","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exceptional Response to Rechallenge Peptide Receptor Radionuclide Therapy in Metastatic Carotid Body Tumor"],"prefix":"10.1097","volume":"51","author":[{"given":"Piyush","family":"Aggarwal","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swayamjeet","family":"Satapathy","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bidya","family":"Sarungbam","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-0361","authenticated-orcid":false,"given":"Ashwani","family":"Sood","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajender","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwant Rai","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"R1-20251210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/000348941112000606","article-title":"Malignant carotid body tumor with systemic metastases","volume":"120","author":"Nishijima","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R2-20251210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41824-024-00211-x","article-title":"Presentation of metastatic carotid body paraganglioma on F-18 FDG PET\/CT: a rare disease","volume":"8","author":"Dulet","year":"2024","journal-title":"EJNMMI Reports"},{"key":"R3-20251210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-023-01314-y","article-title":"Carotid body paraganglioma metastatic to spine causing cord compression: a case report","volume":"18","author":"Tabb","year":"2023","journal-title":"Diagn Pathol"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0145561319863373","article-title":"Is regional lymph node metastasis of head and neck paraganglioma a sign of aggressive clinical behavior: a clinical\/pathologic review","volume":"100","author":"Javidiparsijani","year":"2021","journal-title":"Ear Nose Throat J"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jvs.2022.04.039","article-title":"Epidemiology and survival of patients with malignant carotid body tumors in the SEER database","volume":"76","author":"Li","year":"2022","journal-title":"J Vasc Surg"},{"key":"R6-20251210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cncr.10252","article-title":"National Cancer Data Base report on malignant paragangliomas of the head and neck","volume":"94","author":"Lee","year":"2002","journal-title":"Cancer"},{"key":"R8-20251210","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/cen.14106","article-title":"Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: a systematic review and meta-analysis","volume":"91","author":"Satapathy","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R9-20251210","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1097\/RLU.0000000000004929","article-title":"Complete response to 177 Lu-DOTATATE PRRT in a 9-year-old child with metastatic carotid body paraganglioma","volume":"49","author":"Yadav","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R10-20251210","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/RLU.0000000000000273","article-title":"Peptide receptor radionuclide therapy with 177Lu DOTATATE in a case of recurrent carotid body paraganglioma with spinal metastases","volume":"39","author":"Kumar","year":"2014","journal-title":"Clin Nucl Med"},{"key":"R11-20251210","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1200\/JCO.2010.31.7131","article-title":"Peptide receptor radionuclide therapy in a case of multiple spinal canal and cranial paragangliomas","volume":"29","author":"Cecchin","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:00:51Z","timestamp":1765371651000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005930","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"2025-01-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}